Last updated 3 days ago

Impact of HMB Supplementation on Inflammation and Outcomes in Head and Neck Cancer

66 patients around the world

Available in Brazil

Federal University of Minas Gerais

1Research sites

66Patients around the world

This study is for people with

Head and neck cancer

From 18 Years

All Gender

: Individuals aged 18 years or older.
Both sexes (male and female).
Patients treated at the outpatient clinic for head and neck carcinoma.
Indication for potentially curative tumor resection surgery.

: Diagnosis of cancer of the face, skin, paranasal sinuses, or thyroid.
Undergoing neoadjuvant or palliative treatment.
Cognitive or intellectual impairment that may hinder proper understanding of the study.
Refusal to participate or to sign the informed consent form.

Hospital Das Clínicas Da Universidade Federal de Minas Gerais - UFMG

Recruiting

Av. Prof. Alfredo Balena, 110 2 floor - Room 216 - Santa Efigênia, Belo Horizonte - MG, 30130-100

SponsorFederal University of Minas Gerais

Study typeInterventional

Conditions

Head and neck cancer

Requirements

From 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT07675421